Teva returns laquinimod global rights to Active Biotech
Teva Pharmaceutical Industries has returned global development and commercialisation rights to drug candidate laquinimod to Swedish biotechnology company Active Biotech.…
Teva
-
-
Fasinumab Phase III osteoarthritis trial meets endpoints
Teva Pharmaceutical and Regeneron Pharmaceuticals have reported positive top-line data from a phase III clinical trial of fasinumab to treat…
